您好,欢迎访问细胞应激生物学国家重点实验室(厦门大学) 设为首页 | 加入收藏

当前位置:首页  科学研究  论文专著

2017年代表性论文
出处:细胞应激生物学国家重点实验室 发布时间:2017-03-28 浏览次数:53

论文选取细胞应激生物学国家重点实验室2017年所发表第一单位或通讯作者单位影响因子5以上论文。

1. Yoshikawa T, Wu J, Otsuka M*, Kishikawa T, Suzuki N, Takata A, Ohno M,Ishibashi R, Yamagami M, Nakagawa R, Kato N, Miyazawa M, Han J*, Koike K. Repression of MicroRNA Function Mediates Inflammation-associated Colon Tumorigenesis. Gastroenterology. 152:631-643 (2017).  IF: 18.187

2. Cai WY, Lin LY, Hao H, Zhang SM, Ma F, Hong XX, Zhang H, Liu QF, Ye GD, SunGB, Liu YJ, Li SN, Xie YY, Cai JC, Li BA*. Yes-associated protein/TEA domain family member and hepatocyte nuclear factor 4-alpha (HNF4α) repress reciprocally to regulate hepatocarcinogenesis in rats and mice. Hepatology. 65:1206-1221 (2017).IF: 11.711

3. Bian XL, Chen HZ, Yang PB, Li YP, Zhang FN, Zhang JY, Wang WJ, Zhao WX, ZhangS, Chen QT, Zheng Y, Sun XY, Wang XM, Chien KY, Wu Q*. Nur77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate carboxykinase sumoylation. Nature Communications. 8:14420 (2017).IF: 11.329

4. Zhang Y, Su SS, Zhao S, Yang Z, Zhong CQ, Chen X, Cai Q, Yang ZH, Huang D, WuR, Han J*. RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome. Nature Communications. 8:14329 (2017).IF: 11.329

5. Zhang J, Wang S, Jiang B, Huang L, Ji Z, Li X, Zhou H, Han A, Chen A, Wu Y,Ma H, Zhao W, Zhao Q, Xie C, Sun X, Zhou Y, Huang H, Suleman M, Lin F, Zhou L,Tian F, Jin M, Cai Y, Zhang N, Li Q*. c-Src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis. Nature Communications. 8:13732 (2017).IF: 11.329

6. Li G, Liu X, Xing C, Zhang H, Shimeld SM, Wang Y*. Cerberus-Nodal-Lefty-Pitxsignaling cascade controls left-right asymmetry in amphioxus. PNAS.(2017).   IF: 9.423

7. Jiang J, Gui F, He Z, Li L, Li Y, Li S, Wu X, Deng Z, Sun X, Huang X, HuangW, Han S, Zhang T, Wang Z, Jiao B, Song S, Wang H, Chen L, Zhou D, Liu Q, Ren R, Zhang J, Deng X*. Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors. Cancer Research. 77:175-186 (2017). IF: 8.556

8. Wan W, Peng K, Li M, Qin L, Tong Z, Yan J, Shen B, Yu C*. Histone demethylase JMJD1A promotes urinary bladder cancer progression by enhancing glycolysisthrough coactivation of hypoxia inducible factor 1α. Oncogene. (2017). IF: 7.932

9. Jiang B, Zhang J, Xia J, Zhao W, Wu Y, Shi M, Luo L, Zhou H, Chen A, Ma H, Zhao Q, Suleman M, Lin F, Zhou L, Wang J, Zhang Y, He Y, Li X, Hung LM, Mak TW, Li Q*. IDH1 Mutation Promotes Tumorigenesis by Inhibiting JNK Activation and Apoptosis Induced by Serum Starvation. Cell Rep. 19(2):389-400 (2017). IF: 7.87

10. Cai B, Wu J, Yu X, Su XZ*, Wang RF*. FOSL1 Inhibits Type I Interferon Responsesto Malaria and Viral Infections by Blocking TBK1 and TRAF3/TRIF Interactions. MBio. 8 (2017). IF: 6.975

11. Ge Y, Yan F, Zourelidou M, Wang M, Ljung K, Fastner A, Hammes UZ, Di DonatoM, Geisler M, Schwechheimer C, Tao Y*. SHADE AVOIDANCE 4 Is Required for Proper Auxin Distribution in the Hypocotyl. Plant Physiology. 173:788-800 (2017). IF: 6.28

12. Huang GL, Zhang W, Ren HY, Zhou P, Chen Y, Chen QX*, Shen DY*. Oncogenicretinoic acid receptor α promotes human colorectal cancer growth through simultaneously regulating p21 transcription and GSK3β/β-catenin signaling. Cancer Letter. 388:118-129 (2017). IF: 5.992

13. Hong H, Cai Y, Zhang S, Ding H, Wang H, Han A*. Molecular Basis of Substrate Specific Acetylation by N-Terminal Acetyltransferase NatB. Structure. 25:641-649 (2017). IF: 5.237

14. Wang X, Hong Y, Cai P, Tang N, Chen Y, Yan T, Liu Y, Huang Q, Li Q*. Rapid andReliable Detection of Nonsyndromic Hearing Loss Mutations by Multicolor MeltingCurve Analysis. Scientific Reports. 7:42894 (2017).IF: 5.228

15. Zeng W, Zhang C, Cheng H, Wu YL, Liu J, Chen Z, Huang JG, Ericksen RE, Chen L,Zhang H, Wong AS, Zhang XK, Han W, Zeng JZ*. Targeting to the non-genomic activityof retinoic acid receptor-gamma by acacetin in hepatocellular carcinoma. Scientific Reports. 7:348 (2017).IF: 5.228

16. Wang PY, Zeng WJ, Liu J, Wu YL, Ma Y, Zeng Z, Pang JY, Zhang XK, Yan X, Wong AS, Zeng JZ*. TRC4, an improved triptolide derivative, specifically targets totruncated form of retinoid X receptor-alpha in cancer cells. Biochemical Pharmacology. 124-19-28 (2017).IF: 5.091